Veterinary Medicines Information website

Magniject 250 mg/ml Solution for Injection

Authorised
  • Magnesium sulfate heptahydrate
Download as PDF

Product identification

Medicine name:
Magniject 250 mg/ml Solution for Injection
Active substance:
  • Magnesium sulfate heptahydrate
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Magnesium sulfate heptahydrate
    25.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CC02
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Magniject, a clear colourless solution, is marketed in 400 ml polypropylene container sealed with bromobutyl bung and aluminium cap.
  • Magniject, a clear colourless solution, is marketed in 400 ml Amber Type III glass vial sealed with black rubber wad and aluminium screw cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22664/030/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 25/09/2024
Download